Treatment of non-obese diabetic (NOD)/Severe-combined immunodeficient mice (SCID) with flt3 ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells. (Q51094760)
Jump to navigation
Jump to search
scientific article published in September 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of non-obese diabetic (NOD)/Severe-combined immunodeficient mice (SCID) with flt3 ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells. |
scientific article published in September 1998 |
Statements
Treatment of non-obese diabetic (NOD)/Severe-combined immunodeficient mice (SCID) with flt3 ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells (English)
Kapp U
Bhatia M
Bonnet D
Murdoch B
1 September 1998